Virginia Clinical Research, Inc.
2 clinical trials · Sponsor
◉ Watch Virginia Clinical Research, Inc.
| Record | Firm | Date |
|---|---|---|
| Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1% (NCT06645821) | Virginia Clinical Research, Inc. | 2024-12-03 |
| Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus (NCT01041625) | Virginia Clinical Research, Inc. | 2010-02-01 |
Track Virginia Clinical Research, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.